NCT00105326View on ClinicalTrials.gov

Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

August 31, 2005

Conditions
SchizophreniaInsomnia
Interventions
DRUG

paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00105326 - Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients | Biotech Hunter | Biotech Hunter